Curi Bio lands over $4.4M in NIH grants for two projects

The Seattle-based biotech company is working on projects in Duchenne muscular dystrophy and Botox, which can be used to treat afflictions such as muscle spasms and chronic pain.

First Watch ready to show off its newest look at Dublin restaurant

St. Louis Symphony Orchestra increases revenue, ticket sales in fiscal 2018

October housing market: Nashville home sales down, inventory up

Longtime Seattle-area homebuilder Conner Homes gets new president

Investment management firm to cut 850 jobs in Denver-area office

Hines launches global business unit targeting ESG

Most Admired For-Profit CEO: Welcome Wilson Jr.

Developer requests rezoning for new flex space on Black Bob Road in Olathe

Curi Bio lands over $4.4M in NIH grants for two projects

Previous Drive-in theater signs lease for 10-acre site after closing Mueller location

Next Wisconsin's Venture Investors joins in Visana Health's $10.1M seed round

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Report: 60% of Florida homeowners say they’re putting off home repairs

Aimco breaks ground on $87 million development in Aurora

Jaggers sets opening date for new East End location

Why this Valley Mexican food chain plans to build its own restaurants

Still-new The Grove at Clermont apartments sell in Lake County’s most expensive deal of 2023

Lake Monster founders prepare to debut King Coil Spirits (photos)

MENU

FirstStar Group

More Stories

Fidelity overhauls fees for wealth management clients

Previous Drive-in theater signs lease for 10-acre site after closing Mueller location

Next Wisconsin's Venture Investors joins in Visana Health's $10.1M seed round

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories